In conclusion, our findings underscore a prospective trajectory for future investigations, elucidating the intricate interplay between obesity, T2D, the miR-221-3p/222-3p cluster, and their target genes (ETS1, DVL2, and IL1RAP) in the modulation of AT functionality in the context of both T2D and obesity. This evidence concerns the gene ETS1 and obesity disorder.